• 6366 Citations
  • 22 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Bilal Piperdi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non-Small-Cell Lung Cancer

Mazieres, J., Kowalski, D., Luft, A., Vicente, D., Tafreshi, A., Gümüş, M., Laktionov, K., Hermes, B., Cicin, I., Rodríguez-Cid, J., Wilson, J., Kato, T., Ramlau, R., Novello, S., Reddy, S., Kopp, H. G., Piperdi, B., Li, X., Burke, T. & Paz-Ares, L., Jan 20 2020, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38, 3, p. 271-280 10 p.

Research output: Contribution to journalArticle

  • 14 Scopus citations

    Pembrolizumab for Previously Treated, PD-L1–expressing Advanced NSCLC: Real-world Time on Treatment and Overall Survival

    Velcheti, V., Chandwani, S., Chen, X., Piperdi, B. & Burke, T., Sep 2020, In : Clinical lung cancer. 21, 5, p. e445-e455

    Research output: Contribution to journalArticle

    Open Access
  • Outcomes of first-line pembrolizumab monotherapy for PD-L1-positive (TPS ≥50%) metastatic NSCLC at US oncology practices

    Velcheti, V., Chandwani, S., Chen, X., Pietanza, M. C., Piperdi, B. & Burke, T., 2019, In : Immunotherapy. 11, 18, p. 1541-1554 14 p.

    Research output: Contribution to journalArticle

    Open Access
  • 4 Scopus citations

    Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study

    Leighl, N. B., Hellmann, M. D., Hui, R., Carcereny, E., Felip, E., Ahn, M. J., Eder, J. P., Balmanoukian, A. S., Aggarwal, C., Horn, L., Patnaik, A., Gubens, M., Ramalingam, S. S., Lubiniecki, G. M., Zhang, J., Piperdi, B. & Garon, E. B., Apr 2019, In : The Lancet Respiratory Medicine. 7, 4, p. 347-357 11 p.

    Research output: Contribution to journalArticle

  • 34 Scopus citations

    Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer

    Levy, B. P., Giaccone, G., Besse, B., Felip, E., Garassino, M. C., Domine Gomez, M., Garrido, P., Piperdi, B., Ponce-Aix, S., Menezes, D., MacBeth, K. J., Risueño, A., Slepetis, R., Wu, X., Fandi, A. & Paz-Ares, L., Feb 2019, In : European Journal of Cancer. 108, p. 120-128 9 p.

    Research output: Contribution to journalArticle

  • 13 Scopus citations